Pagkas-Bather, J., Duncan, D. T., Chen, Y.-T., Cursio, J., Del Vecchio, N., Mayer, K. H., Knox, J., Hanson, H., Eavou, R., & Schneider, J. A. (2022). Sleep Disturbance is Associated with Missing PrEP Doses Among Young Black Sexual Minority Men in The N2 study. AIDS and Behavior, 26(12), 3827–3833. https://doi.org/10.1007/s10461-022-03711-8

Fernández-Luis, S., Lain, M. G., Serna-Pascual, M., Domínguez-Rodríguez, S., Kuhn, L., Liberty, A., Barnabas, S., Lopez-Varela, E., Otwombe, K., Danaviah, S., Nastouli, E., Palma, P., Cotugno, N., Spyer, M., Giannuzzi, V., Giaquinto, C., Violari, A., Cotton, M. F., Nhampossa, T., … Maiga, A. (2022). Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-13543-9

Jao, J., Sun, S., Bonner, L. B., Legbedze, J., Mmasa, K. N., Makhema, J., Mmalane, M., Kgole, S., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., Abrams, E. J., Kurland, I. J., Geffner, M. E., & Powis, K. M. (2022). Lower Insulin Sensitivity in Newborns With In Utero HIV and Antiretroviral Exposure Who Are Uninfected in Botswana. The Journal of Infectious Diseases, 226(11), 2002–2009. https://doi.org/10.1093/infdis/jiac416

Murphy, E. C., Danvers, A., Zamudio, A. R., Avila, K., Proehl, M., Gonzalez-Argoti, T., Mantell, J. E., Bauman, L. J., & Dolan, S. M. (2022). “Being able to do whatever you wanna do as a woman is important:” a qualitative exploration of contraception as a frame of reference for HIV prevention with PrEP. Reproductive Health, 19(1). https://doi.org/10.1186/s12978-022-01393-y

Mantell, J., Franks, J., Zerbe, A., Lamb, M. R., Reed, D. M., Omollo, D., Lahuerta, M., Naitore, D., El-Sadr, W. M., & Agot, K. (2022). MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya. BMJ Open, 12(11), e064037. https://doi.org/10.1136/bmjopen-2022-064037

Watson, R. J., Chang, C. J., Feinstein, B. A., Moody, R. L., Caba, A., & Eaton, L. A. (2022). PrEP Stigma and logistical barriers remain significant challenges in curtailing HIV transmission among Black and Hispanic/Latinx cisgender sexual minority men and transgender women in the US. AIDS Care, 34(11), 1465–1472. https://doi.org/10.1080/09540121.2022.2098908

Mudzingwa, E. K., de Vos, L., Atujuna, M., Fynn, L., Mugore, M., Hosek, S., Celum, C., Bekker, L.-G., Daniels, J., & Medina-Marino, A. (2022). Factors influencing adolescent girls and young women’s uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study. AIDS and Behavior, 26(11), 3726–3739. https://doi.org/10.1007/s10461-022-03702-9

Cheek, J. B., Feldman, M. B., Montero, N., Gambone, G. F., Hoffman, S., & Blackstock, O. J. (2022). Pre-exposure Prophylaxis (PrEP) Initiation Among Black and Latina Cisgender Women Receiving HIV Prevention Care Coordination Services in New York City. AIDS and Behavior, 26(10), 3174–3184. https://doi.org/10.1007/s10461-022-03661-1

Spicehandler, R., Zucker, J., Yumori, C., Adan, M., Carnevale, C., Theodore, D., Castor, D., Meyers, K., Whittier, S., Yin, M. T., Cohall, A., Olender, S., Gordon, P., & Sobieszczyk, M. E. (2022). Get2PrEP: An Electronic Medical Record Laboratory Comment Increased Safe Sex Counseling But Not Preexposure Prophylaxis Services at a Large Urban Academic Medical Center in Northern Manhattan. Sexually Transmitted Diseases, 49(10), 713–718. https://doi.org/10.1097/olq.0000000000001682

Bergam, S., Harrison, A. D., Benghu, N., Khumalo, S., Tesfay, N., Exner, T., Miller, L., Dolezal, C., Hanass-Hancock, J., & Hoffman, S. (2022). Women’s Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa. AIDS and Behavior, 26(9), 2881–2890. https://doi.org/10.1007/s10461-022-03632-6

Jacobs, T. G., Schouwenburg, S., Penazzato, M., Archary, M., Ruel, T. D., van den Anker, J., Burger, D. M., Cressey, T. R., Abrams, E. J., Lyall, H., Bekker, A., Colbers, A., Burger, D., Bekker, A., Cressey, T., Hirt, D., Lutsar, I., Mcilleron, H., Standing, J., … Vitoria, M. (2022). What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies. The Lancet HIV, 9(9), e649–e657. https://doi.org/10.1016/s2352-3018(22)00121-7

Morris, S. E., Strehlau, R., Shiau, S., Abrams, E. J., Tiemessen, C. T., Kuhn, L., & Yates, A. J. (2022). Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy. PLOS Pathogens, 18(8), e1010751. https://doi.org/10.1371/journal.ppat.1010751

Heck, C. J., Mathur, S., Alwang’a, H., Daniel, O.-M., Obanda, R., Owiti, M., & Okal, J. (2022). Oral PrEP Consultations Among Adolescent Girls and Young Women in Kisumu County, Kenya: Insights from the DREAMS Program. AIDS and Behavior, 26(8), 2516–2530. https://doi.org/10.1007/s10461-022-03590-z

Medina‐Marino, A., Bezuidenhout, D., Ngwepe, P., Bezuidenhout, C., Facente, S. N., Mabandla, S., Hosek, S., Little, F., Celum, C. L., & Bekker, L. (2022). Acceptability and feasibility of leveraging community‐based HIV counselling and testing platforms for same‐day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa. Journal of the International AIDS Society, 25(7). Portico. https://doi.org/10.1002/jia2.25968

Abrams, E. J., Calmy, A., Fairlie, L., Mahaka, I. C., Chimula, L., Flynn, P. M., Kinuthia, J., Myer, L., Khoo, S. H., Musoke, P., Zwerski, S., Zech, J. M., Lockman, S., & Siberry, G. K. (2022). Approaches to accelerating the study of new antiretrovirals in pregnancy. Journal of the International AIDS Society, 25(S2). Portico. https://doi.org/10.1002/jia2.25916

Mansoor, L. E., Lewis, L., Naicker, C. L., Harkoo, I., Dawood, H., Naidoo, K., Gengiah, T. N., Samsunder, N., Beesham, I., Abdool Karim, S. S., & Abdool Karim, Q. (2022). Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa. Journal of the International AIDS Society, 25(7). Portico. https://doi.org/10.1002/jia2.25957

Unger, Z. D., Golub, S. A., Borges, C., Edelstein, Z. R., Hedberg, T., & Myers, J. (2022). Reasons for PrEP Discontinuation After Navigation at Sexual Health Clinics: Interactions Among Systemic Barriers, Behavioral Relevance, and Medication Concerns. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90(3), 316–324. https://doi.org/10.1097/qai.0000000000002952

Faro, E. Z., Mantell, J. E., Gonzalez-Argoti, T., Hoffman, S., Edelstein, Z., Tsoi, B., & Bauman, L. J. (2022). Implementing PrEP Services in Diverse Health Care Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90(S1), S114–S128. https://doi.org/10.1097/qai.0000000000002971

Knox, J., Kutner, B. A., Shiau, S., Winterhalter, F. S., Wu, Y., Hirsch-Moverman, Y., El-Sadr, W., Colson, P. W., & Franks, J. (2022). Assessing the Information-Motivation-Behavioral Skills Model to Predict Pre-exposure Prophylaxis Adherence Among Black Men Who have Sex with Men and Transgender Women in a Community Setting in New York City. AIDS and Behavior, 26(7), 2494–2502. https://doi.org/10.1007/s10461-022-03588-7

Bazzi, A. R., Valasek, C. J., Streuli, S. A., Vera, C. F., Harvey-Vera, A., Philbin, M. M., Biello, K. B., Roth, A. M., Strathdee, S. A., & Pines, H. A. (2022). Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California. AIDS Patient Care and STDs, 36(7), 254–262. https://doi.org/10.1089/apc.2022.0068

Jennings, L., Robbins, R. N., Nguyen, N., Ferraris, C., Leu, C.-S., Dolezal, C., Hsiao, N., Mgbako, O., Joska, J., Castillo-Mancilla, J. R., Myer, L., Anderson, P. L., Remien, R. H., & Orrell, C. (2022). Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa. AIDS, 36(7), 933–940. https://doi.org/10.1097/qad.0000000000003185

Reidy, W., Kambale, H. N., Hughey, A. B., Nhlengethwa, T. T., Tailor, J., Lukhele, N., Mthethwa, S., Hettema, A., Preko, P., & Rabkin, M. (2022). Client and healthcare worker experiences with differentiated HIV treatment models in Eswatini. PLOS ONE, 17(5), e0269020. https://doi.org/10.1371/journal.pone.0269020

Delany-Moretlwe, S., Hughes, J. P., Bock, P., Ouma, S. G., Hunidzarira, P., Kalonji, D., Kayange, N., Makhema, J., Mandima, P., Mathew, C., Spooner, E., Mpendo, J., Mukwekwerere, P., Mgodi, N., Ntege, P. N., Nair, G., Nakabiito, C., Nuwagaba-Biribonwoha, H., Panchia, R., … Gaffoor, Z. (2022). Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. The Lancet, 399(10337), 1779–1789. https://doi.org/10.1016/s0140-6736(22)00538-4

Carnevale, C., Zucker, J., LaSota, E., Northland, B., Arache, A., Peralta, H., Cohall, A., Garth, J., Gold, M. A., & Sobieszczyk, M. E. (2022). PreexposureProphylaxis at School-Based Health Centers: Awareness and Interest in Starting Preexposure Prophylaxis While Attending a School-Based Health Center in New York City. Journal of Pediatric Health Care, 36(3), 256–263. https://doi.org/10.1016/j.pedhc.2021.10.006

Rowe, K., Theodore, D. A., Zucker, J., Cohensedgh, O., LaSota, E., Carnevale, C., Cohall, A., Olender, S., Gordon, P., & Sobieszczyk, M. E. (2022). Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City. AIDS Patient Care and STDs, 36(4), 153–158. https://doi.org/10.1089/apc.2022.0004

Rathakrishnan, D., Purpura, L. J., Salcuni, P. M., Myers, J. E., Wahnich, A., Daskalakis, D. C., & Edelstein, Z. R. (2021). PrEP Use and Correlates of Use Among a Large, Urban Sample of Men and Transgender Persons Who Have Sex with Men. AIDS and Behavior, 26(4), 1017–1025. https://doi.org/10.1007/s10461-021-03456-w

Philbin, M. M., Bergen, S., Parish, C., Kerrigan, D., Kinnard, E. N., Reed, S., Cohen, M. H., Sosanya, O., Sheth, A. N., Adimora, A. A., Cocohoba, J., Goparaju, L., Golub, E. T., Vaughn, M., Gutierrez, J. I., Fischl, M. A., Alcaide, M., & Metsch, L. R. (2021). Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most. AIDS and Behavior, 26(4), 1260–1269. https://doi.org/10.1007/s10461-021-03483-7

Price, D. M., Unger, Z., Wu, Y., Meyers, K., & Golub, S. A. (2022). Clinic-Level Strategies for Mitigating Structural and Interpersonal HIV Pre-Exposure Prophylaxis Stigma. AIDS Patient Care and STDs, 36(3), 115–122. https://doi.org/10.1089/apc.2021.0176

Philbin, M. M., & Perez-Brumer, A. (2022). Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV. Current Opinion in HIV and AIDS, 17(2), 72–88. https://doi.org/10.1097/coh.0000000000000723

Slogrove, A. L., Burmen, B., Davies, M. A., Edmonds, A., Abrams, E. J., Chadwick, E. G., Goetghebuer, T., Mofenson, L. M., Paul, M. E., Thorne, C., Williams, P. L., Vicari, M., & Powis, K. M. (2021). Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children. Clinical Infectious Diseases, 75(2), 347–355. https://doi.org/10.1093/cid/ciab974

Heck, C. J., & Abdool Karim, Q. (2022). Enhancing oral PrEP uptake among adolescent girls and young women in Africa. Journal of the International AIDS Society, 25(1). Portico. https://doi.org/10.1002/jia2.25876

Gengiah, T. N., Abdool Karim, Q., Harkoo, I., Mansoor, L., Zuma, N. Y., Radebe, P., Samsunder, N., Baxter, C., Maharaj, B., Baum, M. M., Moss, J. A., Pozzetto, B., Hankins, C., & Abdool Karim, S. (2022). CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ Open, 12(1), e052880. https://doi.org/10.1136/bmjopen-2021-052880

Olali, A. Z., Shi, Q., Hoover, D. R., Bucovsky, M., Shane, E., Yin, M. T., & Ross, R. D. (2022). Bone and fat hormonal crosstalk with antiretroviral initiation. Bone, 154, 116208. https://doi.org/10.1016/j.bone.2021.116208

Seekaew, P., Phanuphak, N., Teeratakulpisarn, N., Amatavete, S., Lujintanon, S., Teeratakulpisarn, S., Pankam, T., Nampaisan, O., Jomja, P., Prabjunteuk, C., Plodgratoke, P., Ramautarsing, R., & Phanuphak, P. (2021). Same‐day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort study. Journal of the International AIDS Society, 24(12). Portico. https://doi.org/10.1002/jia2.25869

Mogoba, P., Lesosky, M., Zerbe, A., Falcao, J., Mellins, C. A., Desmond, C., Arnaldo, C., Kapogiannis, B., Myer, L., & Abrams, E. J. (2021). The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial. Trials, 22(1). https://doi.org/10.1186/s13063-021-05943-w

Karim, S. S. A., & Baxter, C. (2021). HIV pre-exposure prophylaxis implementation in Africa: some early lessons. The Lancet Global Health, 9(12), e1634–e1635. https://doi.org/10.1016/s2214-109x(21)00460-5

Amatavete, S., Lujintanon, S., Teeratakulpisarn, N., Thitipatarakorn, S., Seekaew, P., Hanaree, C., Sripanjakun, J., Prabjuntuek, C., Suwannarat, L., Phattanathawornkool, T., Photisan, N., Suriwong, S., Avery, M., Mills, S., Phanuphak, P., Phanuphak, N., & Ramautarsing, R. A. (2021). Evaluation of the integration of telehealth into the same‐day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID‐19: a mixed‐method analysis of real‐world data. Journal of the International AIDS Society, 24(S6). Portico. https://doi.org/10.1002/jia2.25816

Saito, A., & Yamashita, M. (2021). HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules. Retrovirology, 18(1). https://doi.org/10.1186/s12977-021-00577-x

Bardon, A. R., Dorward, J., Sookrajh, Y., Sayed, F., Quame-Amaglo, J., Pillay, C., Feutz, E., Ngobese, H., Simoni, J. M., Sharma, M., Cressey, T. R., Gandhi, M., Lessells, R., Moodley, P., Naicker, N., Naidoo, K., Thomas, K., Celum, C., Abdool Karim, S., … Drain, P. K. (2021). Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes. BMJ Open, 11(10), e050116. https://doi.org/10.1136/bmjopen-2021-050116

Reif, L. K., Belizaire, M. E., Rouzier, V., Seo, G., Severe, P., Bajo Joseph, J.-M., Joseph, B., Apollon, S., Pape, J. W., McNairy, M. L., Elul, B., Fitzgerald, D. W., Arpadi, S. M., Abrams, E. J., & Kuhn, L. (2021). Point-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial. AIDS Care, 34(4), 409–420. https://doi.org/10.1080/09540121.2021.1981816

van Santen, D. K., Asselin, J., Haber, N. A., Traeger, M. W., Callander, D., Donovan, B., El-Hayek, C., McMahon, J. H., Petoumenos, K., McManus, H., Hoy, J. F., Hellard, M., Guy, R., Stoové, M., Carr, A., Elliot, J., Templeton, D. J., Liaw, T., & Wilson, D. P. (2021). Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012–19): a longitudinal cohort study. The Lancet HIV, 8(10), e623–e632. https://doi.org/10.1016/s2352-3018(21)00155-7

Franks, J., Teasdale, C., Olsen, H., Wang, C., Mushimebele, N., Tenda Mazala, R., Tchissambou, T., Malele Bazola, F., Bingham, T., Djomand, G., Mukinda, E., Ewetola, R., Abrams, E., & Reidy, W. (2021). PrEP for key populations: results from the first PrEP demonstration project in the Democratic Republic of the Congo. AIDS Care, 34(3), 359–362. https://doi.org/10.1080/09540121.2021.1969332